Literature DB >> 19066585

Electroporation of mycobacteria.

Renan Goude1, Tanya Parish.   

Abstract

High efficiency transformation is a major limitation in the study of mycobacteria. The genus Mycobacterium can be difficult to transform; this is mainly caused by the thick and waxy cell wall, but is compounded by the fact that most molecular techniques have been developed for distantly-related species such as Escherichia coli and Bacillus subtilis. In spite of these obstacles, mycobacterial plasmids have been identified and DNA transformation of many mycobacterial species have now been described. The most successful method for introducing DNA into mycobacteria is electroporation. Many parameters contribute to successful transformation; these include the species/strain, the nature of the transforming DNA, the selectable marker used, the growth medium, and the conditions for the electroporation pulse. Optimized methods for the transformation of both slow- and fast-grower are detailed here. Transformation efficiencies for different mycobacterial species and with various selectable markers are reported.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19066585      PMCID: PMC2583020          DOI: 10.3791/761

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  8 in total

1.  The nonmevalonate pathway of isoprenoid biosynthesis in Mycobacterium tuberculosis is essential and transcriptionally regulated by Dxs.

Authors:  Amanda C Brown; Matthias Eberl; Dean C Crick; Hassan Jomaa; Tanya Parish
Journal:  J Bacteriol       Date:  2010-02-19       Impact factor: 3.490

2.  Development of a new generation of vectors for gene expression, gene replacement, and protein-protein interaction studies in mycobacteria.

Authors:  Amit Parikh; Devanand Kumar; Yogesh Chawla; Krishna Kurthkoti; Shazia Khan; Umesh Varshney; Vinay K Nandicoori
Journal:  Appl Environ Microbiol       Date:  2013-01-11       Impact factor: 4.792

3.  The dUTPase enzyme is essential in Mycobacterium smegmatis.

Authors:  Ildiko Pecsi; Rita Hirmondo; Amanda C Brown; Anna Lopata; Tanya Parish; Beata G Vertessy; Judit Tóth
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240

4.  Mycobacterium tuberculosis PE_PGRS41 Enhances the Intracellular Survival of M. smegmatis within Macrophages Via Blocking Innate Immunity and Inhibition of Host Defense.

Authors:  Wanyan Deng; Quanxin Long; Jie Zeng; Ping Li; Wenmin Yang; Xinchun Chen; Jianping Xie
Journal:  Sci Rep       Date:  2017-04-25       Impact factor: 4.379

5.  S-Enantiomer of the Antitubercular Compound S006-830 Complements Activity of Frontline TB Drugs and Targets Biogenesis of Mycobacterium tuberculosis Cell Envelope.

Authors:  Padam Singh; Shashi Kant Kumar; Vineet Kumar Maurya; Basant Kumar Mehta; Hafsa Ahmad; Anil Kumar Dwivedi; Vinita Chaturvedi; Tejender S Thakur; Sudhir Sinha
Journal:  ACS Omega       Date:  2017-11-30

6.  Deficiency of GntR Family Regulator MSMEG_5174 Promotes Mycobacterium smegmatis Resistance to Aminoglycosides via Manipulating Purine Metabolism.

Authors:  Wanyan Deng; Zengzhang Zheng; Yi Chen; Maoyi Yang; Jun Yan; Wu Li; Jie Zeng; Jianping Xie; Sitang Gong; Huasong Zeng
Journal:  Front Microbiol       Date:  2022-07-11       Impact factor: 6.064

7.  Diaza-anthracene Antibiotics from a Freshwater-Derived Actinomycete with Selective Antibacterial Activity toward Mycobacterium tuberculosis.

Authors:  Michael W Mullowney; Chang Hwa Hwang; Andrew G Newsome; Xiaomei Wei; Urszula Tanouye; Baojie Wan; Skylar Carlson; Nanthida Joy Barranis; EoghainínÓ hAinmhire; Wei-Lun Chen; Kalyanaraman Krishnamoorthy; John White; Rachel Blair; Hyunwoo Lee; Joanna E Burdette; Pradipsinh K Rathod; Tanya Parish; Sanghyun Cho; Scott G Franzblau; Brian T Murphy
Journal:  ACS Infect Dis       Date:  2015-03-11       Impact factor: 5.084

8.  Mycobacterium tuberculosis Rv1152 is a Novel GntR Family Transcriptional Regulator Involved in Intrinsic Vancomycin Resistance and is a Potential Vancomycin Adjuvant Target.

Authors:  Jie Zeng; Wanyan Deng; Wenmin Yang; Hongping Luo; Xiangke Duan; Longxiang Xie; Ping Li; Rui Wang; Tiwei Fu; Abualgasim Elgaili Abdalla; Jianping Xie
Journal:  Sci Rep       Date:  2016-06-28       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.